Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouA Saudi brand commissioning a custom face cream from an overseas OEM laboratory usually assumes one question — “who owns the formula?” — has one answer. In practice, three parties hold three different kinds…
A Saudi brand commissioning a custom face cream from an overseas OEM laboratory usually assumes one question — “who owns the formula?” — has one answer. In practice, three parties hold three different kinds of control, and the gaps between them are exactly where launches stall. The brand controls the market, the price architecture and the claims. The overseas lab controls the formula as a manufacturing instruction, together with the batch records and release criteria. The Saudi importer or notifier carries the legal responsibility for placing the product on the market, including SFDA cosmetic notification under the GSO safety and claims framework. This guide maps those boundaries and lists the documents to request so that control is defined in writing before the first pilot batch — not discovered after the first shipment.
| Decision area | Saudi brand | Overseas OEM lab | Importer / notifier |
|---|---|---|---|
| Target market and positioning | Decides | Advises on what is technically feasible | Confirms the entry route and local requirements |
| Formula composition and process | Approves the brief and the golden sample | Owns and controls | Receives a summary for the dossier |
| Exclusivity (who else receives the base) | Negotiates scope and term | Grants only within the signed contract scope | Not involved |
| Technical dossier: INCI, COA, SDS, specs, stability, micro | Receives a complete copy | Authors and signs | Holds it for notification and inspection |
| Label artwork and language | Approves brand content | Supplies technical input (INCI, net content, usage) | Approves the final Arabic/English text |
| Claims and advertising | Decides, within evidence | Verifies technical accuracy of wording | Checks market compliance |
| Notification and import permit | Funds and supports | Provides supporting documents | Files and holds the record |
| Change control (reformulation, supplier swap) | Approves before implementation | Notifies and re-validates | Updates the dossier if the change is material |
Most OEM laboratories bring background intellectual property: existing emulsion platforms, established preservation systems, supplier-approved raw material combinations. Your custom work is usually built on top of that base. The contract should separate background IP from project-specific development, name the formula by its internal code, and state what happens to the documentation if the relationship ends. Without that clause, “we developed it together” is the only thing either side can prove.
Even when a brand owns the recipe text, it does not automatically own the ability to make it. A face cream depends on phase temperatures, homogenization speed and time, cooling ramp, pH adjustment point, preservative addition temperature, fill temperature and a viscosity window. Ask for the scope of the technical transfer package in writing, and expect that a second manufacturing site will still need engineering batches to match texture and stability.
For Saudi entry, the notifier needs a coherent, consistent dossier. Two failures recur: the INCI printed on the label does not match the INCI implied by the quantitative formula, and the stability or microbiology data was generated on a laboratory batch rather than a production-representative batch. Both are avoidable if the documentation is treated as one package from the start rather than assembled at the end.
Claims belong to the brand, but they are constrained by the evidence the factory and the labs can support. Under the SFDA and GSO framework, a cosmetic may not carry drug or therapeutic claims. Aromatherapy-style wording — sleep support, anxiety relief, treatment of a skin condition — can change how the product is classified and create a compliance problem that no amount of good packaging will fix.
| Document or test | What it proves | Issued by |
|---|---|---|
| Quantitative formula, referenced by code | What is actually being manufactured | OEM laboratory |
| INCI declaration plus fragrance allergen calculation | That the label matches the formula at use concentration | OEM laboratory |
| Finished-product specification sheet | Release criteria: appearance, pH, viscosity, odor, identity checks | OEM laboratory |
| Batch COA and retention sample policy | Batch-level conformity and traceability | OEM quality control |
| SDS in GHS format | Handling, storage and transport requirements | OEM laboratory |
| Stability data: accelerated, real-time, and high-temperature cycling | Shelf life claim and resistance to Saudi summer and shipment conditions | OEM laboratory or third-party lab |
| Preservative efficacy (challenge test) and microbiological testing | That the preservation system holds under real use | Third-party laboratory |
| Packaging compatibility report | That jar, airless pack or pump, liner and label survive the product | OEM plus packaging supplier |
| GMP evidence: ISO 22716 / GMPC certificate with facility scope | Process and hygiene control at the actual production site | OEM laboratory |
| Artwork file with Arabic/English text | Market-ready label compliant with SFDA/GSO requirements | Brand plus notifier |
| Gate | Output | Sign-off |
|---|---|---|
| G0 Requirement intake | Project brief with market, price band and channel | Brand |
| G1 Project set-up | Risk list including regulatory and packaging risks | Brand and OEM |
| G2 Sample review | Candidate textures and structured feedback form | Brand |
| G3 Engineering verification | Test records, stability and compatibility data | OEM quality |
| G4 Pilot confirmation | Pilot report and approved golden sample | Brand and OEM |
| G5 Bulk release | Release records and retention samples | OEM quality control |
| G6 Repurchase review | Improvement list and repeat-order plan | Both parties |
Stability, microbiology and packaging compatibility run in parallel with artwork development. Notification can only be filed once the formula and the final label are frozen, so those two freeze dates — not the production date — usually determine the launch date.
Not automatically. Ownership depends on how the contract separates background IP — the OEM’s existing platforms — from project-specific development. Ask for a written IP schedule that names the formula by code and states what transfers to you and what remains with the laboratory.
Only if the contract grants data-transfer rights and the OEM provides a defined transfer package. Even then, expect engineering batches: process parameters such as homogenization speed, cooling ramp and fill temperature determine texture and stability as much as the ingredient list does.
The local importer or notifier carries the legal responsibility for the product on the Saudi market, including notification through the SFDA system and maintaining the product information file. The overseas factory is responsible for the truth and completeness of the technical data it supplies. A completed notification is a regulatory step, not an endorsement of the product.
Barrier-support wording may be acceptable if you hold supporting evidence and it stays within cosmetic framing. Therapeutic and aromatherapy claims — treating a skin condition, improving sleep, relieving anxiety — can reclassify the product and should be avoided unless your regulatory adviser confirms otherwise.
It depends on how much of the formula is genuinely custom. The long poles are usually stability and microbiology testing, packaging compatibility, and label approval with the notifier. Brands that freeze the formula and artwork early typically compress the schedule far more than brands that re-open the brief during pilot.
Send the brief with the target market, SKU count and formats, positioning, packaging direction and target launch date, and you will get a faster, more accurate quotation with the matching documentation list. Request a Quote
This article is informational only and is not legal advice. SFDA and GSO requirements, contract terms and label content should be confirmed with your regulatory consultant and legal counsel.